MADRIGAL PHARMACEUTICALS, INC. Quarterly Depreciation, Depletion and Amortization in USD from Q1 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Madrigal Pharmaceuticals, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2011 to Q1 2024.
  • Madrigal Pharmaceuticals, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $168K, a 35.5% increase year-over-year.
  • Madrigal Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2023 was $527K, a 12.8% increase from 2022.
  • Madrigal Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2022 was $467K, a 15.3% increase from 2021.
  • Madrigal Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2021 was $405K, a 14% decline from 2020.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $168K +$44K +35.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q1 2023 $124K +$17K +15.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2022 $107K -$6K -5.31% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $113K -$12K -9.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q1 2020 $125K +$97K +346% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 $28K +$5K +21.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 $23K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q1 2016 $539K $46K -$123K -72.8% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $662K $193K -$12K -5.85% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-15
Q3 2015 $674K $200K $0 0% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $674K $100K $0 0% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $674K $169K +$1K +0.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $673K $205K -$11K -5.09% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 $684K $200K +$100K +100% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $584K $100K $0 0% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 $584K $168K +$68K +68% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 $516K $216K +$208K +2600% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 $308K $100K -$100K -50% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $408K $100K -$200K -66.7% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 $608K $100K -$130K -56.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $738K $8K -$217K -96.4% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-12
Q3 2012 $955K $200K -$200K -50% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-04
Q2 2012 $1.16M $300K -$100K -25% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-01
Q1 2012 $1.26M $230K -$209K -47.6% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-30
Q4 2011 $1.46M $225K Oct 1, 2011 Dec 31, 2011 10-K 2014-03-11
Q3 2011 $400K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $400K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-02
Q1 2011 $439K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.